 HANOVER, MD, March 02, 2021 GLOBE NEWSWIRE -- Processa Pharmaceuticals, Inc. Nasdaq: PCSA is pleased to announce it has closed its previously announced private placement to institutional and accredited investors of 10.2 million. The Company sold 1,321,132 shares of the common stock at a purchase price of 7.75 per share for 10.2 million in the private placement. The Company received net proceeds of 9.9 million. 